ICT MEDICAL / MEDICAL & AESTHETIC TECHNOLOGIESFOR PROFESSIONAL PARTNERS
SI BELLE / INDIVIDUAL PRODUCT PROFILE

Si Belle PLLA+ 380

PLLA + HA + mannitol profile

The supplied PLLA+ 380 box separately declares poly-L-lactic acid, two HA fractions and mannitol. It is not treated as the same formulation as PLLA+ 400.

Original PLLA+ 380 packaging supplied by the client; not regenerated.
Original PLLA+ 380 packaging supplied by the client; not regenerated.
PRODUCT INFORMATION

Product identity.

The supplied PLLA+ 380 box separately declares poly-L-lactic acid, two HA fractions and mannitol. It is not treated as the same formulation as PLLA+ 400.

380 mg × 1 vial — pack declaration

SOURCE · Original PLLA+ 380 box artwork; portfolio p.10
PRODUCT INFORMATION

What the source declares.

FieldSource-supported information
Poly-L-lactic acid200 mg — pack declaration
H-HA + L-HA40 mg + 40 mg — pack declaration
Mannitol100 mg — pack declaration
Total labelled content380 mg × 1 vial
Pack wordingFUNCTION: Facial Serum; For external use only; For professional use only
SOURCE · Original PLLA+ 380 box artwork; portfolio p.10
PRODUCT INFORMATION

Scope of the current product information.

Full formulation, intended use, storage, shelf life and market status should be checked against the current model-specific documents before supply. No treatment instructions or outcomes are inferred from the product name.

SOURCE · Original PLLA+ 380 box artwork; portfolio p.10
PROFESSIONAL RESOURCES

Request this product’s documents.

Source documentOriginal pack artwork and family portfolio reference
Request document ↗
Current IFU & specificationRequest the current model-specific instructions and technical data.
Request document ↗
Market-specific documentationRequest classification and supply-status documentation for your country.
Request document ↗
ICT MEDICAL / PROFESSIONAL ENQUIRIES

Discuss the product. Request the right documents.

Product information · Technical documentation · Partnership discussions

Speak with ICT Medical